Nasonex Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials
• Forums

Safety and Efficacy of Mometasone Furoate (SCH 032088) vs Beclomethasone Dipropionate or Placebo in Seasonal Allergic Rhinitis (C93-013)
Condition:   Seasonal Allergic Rhinitis Interventions:   Drug: Mometasone Furoate (MF);   Drug: Beclomethasone Dipropionate (BDP);   Drug: Placebo Sponsor:   Merck Sharp & Dohme Corp. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2019 Category: Research Source Type: clinical trials

Safety and Efficacy of Mometasone Furoate Nasal Spray With the Addition of Loratadine Versus Placebo in Participants With Seasonal Allergic Rhinitis (C94-145)
Condition:   Rhinitis, Allergic Interventions:   Drug: Mometasone furoate nasal spray (MFNS);   Drug: Loratadine;   Drug: Placebo nasal spray;   Drug: Placebo tablet Sponsor:   Merck Sharp & Dohme Corp. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2019 Category: Research Source Type: clinical trials

Safety and Efficacy of Mometasone Furoate (SCH 032088) vs Beclomethasone Dipropionate or Placebo in Seasonal Allergic Rhinitis (C93-013)
Condition:   Seasonal Allergic Rhinitis Interventions:   Drug: Mometasone Furoate (MF);   Drug: Beclomethasone Dipropionate (BDP);   Drug: Placebo Sponsor:   Merck Sharp & Dohme Corp. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2019 Category: Research Source Type: clinical trials

Safety and Efficacy of Mometasone Furoate Nasal Spray With the Addition of Loratadine Versus Placebo in Participants With Seasonal Allergic Rhinitis (C94-145)
Condition:   Rhinitis, Allergic Interventions:   Drug: Mometasone furoate nasal spray (MFNS);   Drug: Loratadine;   Drug: Placebo nasal spray;   Drug: Placebo tablet Sponsor:   Merck Sharp & Dohme Corp. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2019 Category: Research Source Type: clinical trials

Safety and Efficacy of Mometasone Furoate (SCH 032088) vs Beclomethasone Dipropionate or Placebo in Seasonal Allergic Rhinitis (C93-013)
Condition:   Seasonal Allergic Rhinitis Interventions:   Drug: Mometasone Furoate (MF);   Drug: Beclomethasone Dipropionate (BDP);   Drug: Placebo Sponsor:   Merck Sharp & Dohme Corp. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2019 Category: Research Source Type: clinical trials

Safety and Efficacy of Mometasone Furoate Nasal Spray With the Addition of Loratadine Versus Placebo in Participants With Seasonal Allergic Rhinitis (C94-145)
Condition:   Rhinitis, Allergic Interventions:   Drug: Mometasone furoate nasal spray (MFNS);   Drug: Loratadine;   Drug: Placebo nasal spray;   Drug: Placebo tablet Sponsor:   Merck Sharp & Dohme Corp. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2019 Category: Research Source Type: clinical trials

Safety and Efficacy of Mometasone Furoate (SCH 032088) vs Beclomethasone Dipropionate or Placebo in Seasonal Allergic Rhinitis (C93-013)
Condition:   Seasonal Allergic Rhinitis Interventions:   Drug: Mometasone Furoate (MF);   Drug: Beclomethasone Dipropionate (BDP);   Drug: Placebo Sponsor:   Merck Sharp & Dohme Corp. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2019 Category: Research Source Type: clinical trials

Safety and Efficacy of Mometasone Furoate Nasal Spray With the Addition of Loratadine Versus Placebo in Participants With Seasonal Allergic Rhinitis (C94-145)
Condition:   Rhinitis, Allergic Interventions:   Drug: Mometasone furoate nasal spray (MFNS);   Drug: Loratadine;   Drug: Placebo nasal spray;   Drug: Placebo tablet Sponsor:   Merck Sharp & Dohme Corp. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2019 Category: Research Source Type: clinical trials

Safety and Efficacy of Mometasone Furoate (SCH 032088) vs Beclomethasone Dipropionate or Placebo in Seasonal Allergic Rhinitis (C93-013)
Condition:   Seasonal Allergic Rhinitis Interventions:   Drug: Mometasone Furoate (MF);   Drug: Beclomethasone Dipropionate (BDP);   Drug: Placebo Sponsor:   Merck Sharp & Dohme Corp. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2019 Category: Research Source Type: clinical trials

Safety and Efficacy of Mometasone Furoate Nasal Spray With the Addition of Loratadine Versus Placebo in Participants With Seasonal Allergic Rhinitis (C94-145)
Condition:   Rhinitis, Allergic Interventions:   Drug: Mometasone furoate nasal spray (MFNS);   Drug: Loratadine;   Drug: Placebo nasal spray;   Drug: Placebo tablet Sponsor:   Merck Sharp & Dohme Corp. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2019 Category: Research Source Type: clinical trials

Safety and Efficacy of Mometasone Furoate (SCH 032088) vs Beclomethasone Dipropionate or Placebo in Seasonal Allergic Rhinitis (C93-013)
Condition:   Seasonal Allergic Rhinitis Interventions:   Drug: Mometasone Furoate (MF);   Drug: Beclomethasone Dipropionate (BDP);   Drug: Placebo Sponsor:   Merck Sharp & Dohme Corp. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2019 Category: Research Source Type: clinical trials

Safety and Efficacy of Mometasone Furoate Nasal Spray With the Addition of Loratadine Versus Placebo in Participants With Seasonal Allergic Rhinitis (C94-145)
Condition:   Rhinitis, Allergic Interventions:   Drug: Mometasone furoate nasal spray (MFNS);   Drug: Loratadine;   Drug: Placebo nasal spray;   Drug: Placebo tablet Sponsor:   Merck Sharp & Dohme Corp. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2019 Category: Research Source Type: clinical trials

Safety and Efficacy of Mometasone Furoate (SCH 032088) vs Beclomethasone Dipropionate or Placebo in Seasonal Allergic Rhinitis (C93-013)
Condition:   Seasonal Allergic Rhinitis Interventions:   Drug: Mometasone Furoate (MF);   Drug: Beclomethasone Dipropionate (BDP);   Drug: Placebo Sponsor:   Merck Sharp & Dohme Corp. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2019 Category: Research Source Type: clinical trials